News
-
-
PRESS RELEASE
Julius Baer announces CHF 600 million share buy-back and revised capital distribution policy
Julius Baer Group Ltd. announces CHF 600 million share buy-back programme and revised capital distribution policy. The new share buy-back programme is expected to launch in the coming weeks and be completed within one year -
-
PRESS RELEASE
Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch
Amoéba finalizes funding plan with a €10 million capital increase through share subscription warrants for future commercial and cosmetics business developments -
-
-
-
-
PRESS RELEASE
Le prix des carburants renforce la demande de voitures électriques – plus d'une auto sur trois vendue en septembre est une BEV
Le marché suisse des voitures neuves sous tension avec une hausse des immatriculations de 2,7 % en septembre. Les ventes de voitures électriques augmentent suite au prix record des carburants -
PRESS RELEASE
19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD
Phase III data of Hansoh Pharma's Olatorepatide, a dual-biased GLP-1/GIP agonist, showing 19.3% weight loss efficacy at Week 48 presented at EASD. Study demonstrates significant weight loss benefits and metabolic improvements
